Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumor specific monoclonal antibodies

Tumor specific monoclonal antibodies

US Patent 5180814 · Granted Jan 19, 1993

Estimated economic value: $1,138,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Autologous tumor vaccines and methods2022
Botulinum antitoxin compositions and methods2013
Sterile immunogenic non-tumorigenic tumor cell compositions and methods2009
Sterile immunogenic non-tumorigenic tumor cell compositions and methods2009
Tumor associated epitope1999
Tumor associated epitope1999
Tumor associated epitope1999
CTAA 28A32, the antigen recognized by MCA 28A321996
Tumor associated monoclonal antibody 123AV161996
Active specific immunotherapy1996
Active specific immunotherapy1996
Tumor associated monoclonal antibodies1995